Skip to main content

View full-text article in PMC

. Author manuscript; available in PMC: 2010 Jul 22.

Published in final edited form as: Circulation. 2003 Jul 14;108(4):395–398. doi: 10.1161/01.CIR.0000084500.72232.8D

TABLE 2.

Tissue Doppler Velocities

	Control Subjects (n=12)		Mutation-Positive Subjects Without Hypertrophy (n=12)
	Baseline	Follow-Up	Baseline	Follow-Up
Lateral Sa, cm/s	15.6±2	15±1.2	8.7±1.7^*	8.2±2.1^*
Lateral Ea, cm/s	16±2.5	16.5±2.8	9.5±2^*	8.1±2.3^*^†
Lateral Aa, cm/s	9.4±1.1	9.1±1.5	9.8±2.2	8.3±1.4^*^†
Lateral Ea/Aa	1.8±0.3	1.8±0.4	0.92±0.3^*	0.95±0.3^*
Lateral E/Ea	5.4±1.45	5.3±1.8	7.99±1.4^*	10±1.7^*^†
Septal Sa, cm/s	14.5±1.4	13±1.2	7.96±1.6^*	7.4±1.9^*
Septal Ea, cm/s	15±2	14.7±2.5	8.5±2.27^*	7.8±2.5^*^†
Septal Aa, cm/s	9.2±1.6	9.2±1.8	9.5±2.8	8.3±2.1^*^†
Septal Ea/Aa	1.85±0.34	1.8±0.26	0.93±0.4^*	0.94±0.2^*
Septal E/Ea	5.8±0.92	5.6±0.92	8.65±1.5^*	10.26±2^*^†

^*

P<0.01 vs control subjects both at baseline and follow-up.

^†

P≤0.01 vs mutation-positive subjects at baseline.